Literature DB >> 19817020

Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19817020

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  4 in total

1.  Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development.

Authors:  Mariette F Ducatez; Justin Bahl; Yolanda Griffin; Evelyn Stigger-Rosser; John Franks; Subrata Barman; Dhanasekaran Vijaykrishna; Ashley Webb; Yi Guan; Robert G Webster; Gavin J D Smith; Richard J Webby
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 2.  H5N1 vaccines in humans.

Authors:  Mariana Baz; Catherine J Luke; Xing Cheng; Hong Jin; Kanta Subbarao
Journal:  Virus Res       Date:  2013-05-28       Impact factor: 3.303

3.  A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.

Authors:  Feng Liu; Xiangjie Sun; Jeffery Fairman; David B Lewis; Jacqueline M Katz; Min Levine; Terrence M Tumpey; Xiuhua Lu
Journal:  Virology       Date:  2016-03-21       Impact factor: 3.616

4.  Developing vaccines to combat pandemic influenza.

Authors:  James S Robertson; Othmar G Engelhardt
Journal:  Viruses       Date:  2010-02-02       Impact factor: 5.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.